Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 3/2014

01.05.2014 | Original Article

Natural history of Sanfilippo syndrome type A

verfasst von: Dakota Buhrman, Kavita Thakkar, Michele Poe, Maria L. Escolar

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

To describe the natural history of Sanfilippo syndrome type A.

Methods

We performed a retrospective review of 46 children (21 boys, 25 girls) with Sanfilippo syndrome type A evaluated between January 2000 and April 2013. Assessments included neurodevelopmental evaluations, audiologic testing, and assessment of growth, adaptive behavior, cognitive behavior, motor function, and speech/language skills. Only the baseline evaluation was included for patients who received hematopoietic stem cell transplantation.

Results

Median age at diagnosis was 35 months, with a median delay between initial symptoms to diagnosis of 24 months. The most common initial symptoms were speech/language delay (48 %), dysmorphology (22 %), and hearing loss (20 %). Early behavioral problems included perseverative chewing and difficulty with toilet training. All children developed sleep difficulties and behavioral changes (e.g., hyperactivity, aggression). More than 93 % of the children experienced somatic symptoms such as hepatomegaly (67 %), abnormal dentition (39 %), enlarged tongue (37 %), coarse facial features (76 %), and protuberant abdomen (43 %). Kaplan-Meier analysis showed a 60 % probability of surviving past 17 years of age.

Conclusions

Sanfilippo type A is characterized by severe hearing loss and speech delay, followed by a rapid decline in cognitive skills by 3 years of age. Significant somatic disease occurs in more than half of patients. Behavioral difficulties presented between 2 and 4 years of age during a rapid period of cognitive decline. Gross motor abilities are maintained during this period, which results in an active child with impaired cognition. Sleep difficulties are concurrent with the period of cognitive degeneration. There is currently an unacceptable delay in diagnosis, highlighting the need to increase awareness of this disease among clinicians.
Literatur
Zurück zum Zitat Baehner F, Schmiedeskamp C, Krummenauer F et al (2005) Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28:1011–1017PubMedCrossRef Baehner F, Schmiedeskamp C, Krummenauer F et al (2005) Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28:1011–1017PubMedCrossRef
Zurück zum Zitat Bruininks R, Woodcock R, Weatherman R, Hill B (1996) Scales of independent behaviour-revised. Riverside, Chicago Bruininks R, Woodcock R, Weatherman R, Hill B (1996) Scales of independent behaviour-revised. Riverside, Chicago
Zurück zum Zitat Crawley AC, Marshall N, Beard H et al (2011) Enzyme replacement reduces neuropathology in MPS IIIA dogs. Neurobiol Dis 43:422–434PubMedCrossRef Crawley AC, Marshall N, Beard H et al (2011) Enzyme replacement reduces neuropathology in MPS IIIA dogs. Neurobiol Dis 43:422–434PubMedCrossRef
Zurück zum Zitat Elliott CD (1990) The Differential Ability Scales (DAS). The Psychological Corp, San Antonio Elliott CD (1990) The Differential Ability Scales (DAS). The Psychological Corp, San Antonio
Zurück zum Zitat Folio M, Fewell R (2000) Peabody developmental motor scales, 2nd edn. Pro-Ed, Austin Folio M, Fewell R (2000) Peabody developmental motor scales, 2nd edn. Pro-Ed, Austin
Zurück zum Zitat Héron B, Mikaeloff Y, Froissart R et al (2011) Incidence and natural history ofmucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A 155A:58–68PubMedCrossRef Héron B, Mikaeloff Y, Froissart R et al (2011) Incidence and natural history ofmucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A 155A:58–68PubMedCrossRef
Zurück zum Zitat Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11:246 Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11:246
Zurück zum Zitat Langford-Smith A, Wilkinson FL, Langford-Smith KJ et al (2012) Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice. Mol Ther: J Am Soc Gene Ther 20:1610–1621CrossRef Langford-Smith A, Wilkinson FL, Langford-Smith KJ et al (2012) Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice. Mol Ther: J Am Soc Gene Ther 20:1610–1621CrossRef
Zurück zum Zitat Malm G, Mansson JE (2010) Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period. Acta Paediatr 99:1253–1257PubMedCrossRef Malm G, Mansson JE (2010) Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period. Acta Paediatr 99:1253–1257PubMedCrossRef
Zurück zum Zitat Martin HR, Poe MD, Reinhartsen D et al (2008) Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective. Acta Paediatr Suppl 97:69–75PubMedCrossRef Martin HR, Poe MD, Reinhartsen D et al (2008) Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective. Acta Paediatr Suppl 97:69–75PubMedCrossRef
Zurück zum Zitat Meyer A, Kossow K, Gal A et al (2007) Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics 120:e1255–e1261PubMedCrossRef Meyer A, Kossow K, Gal A et al (2007) Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics 120:e1255–e1261PubMedCrossRef
Zurück zum Zitat Meyer A, Kossow K, Gal A et al (2008) The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). Hum Mutat 29:770PubMedCrossRef Meyer A, Kossow K, Gal A et al (2008) The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). Hum Mutat 29:770PubMedCrossRef
Zurück zum Zitat Mullen E (1995) The mullen scales of early learning. American Guidance Service, Circle Pines Mullen E (1995) The mullen scales of early learning. American Guidance Service, Circle Pines
Zurück zum Zitat Piotrowska E, Jakobkiewicz-Banecka J, Maryniak A et al (2011) Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients. Med Sci Monit 17:CR196–CR202PubMedCentralPubMedCrossRef Piotrowska E, Jakobkiewicz-Banecka J, Maryniak A et al (2011) Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients. Med Sci Monit 17:CR196–CR202PubMedCentralPubMedCrossRef
Zurück zum Zitat Prasad VK, Mendizabal A, Parikh SH, Szabolcs P et al (2008) Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112:2979–2989PubMedCentralPubMedCrossRef Prasad VK, Mendizabal A, Parikh SH, Szabolcs P et al (2008) Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112:2979–2989PubMedCentralPubMedCrossRef
Zurück zum Zitat Semel E, Wiig E, Secord W (2003) Clinical evaluation of language fundamentals, 4th edn. The Psychological Corporation, San Antonio Semel E, Wiig E, Secord W (2003) Clinical evaluation of language fundamentals, 4th edn. The Psychological Corporation, San Antonio
Zurück zum Zitat Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA (2008) Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 31:240–252PubMedCrossRef Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA (2008) Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 31:240–252PubMedCrossRef
Zurück zum Zitat Valstar MJ, Neijs S, Bruggenwirth HT et al (2010) Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations. Ann Neurol 68:876–887PubMedCrossRef Valstar MJ, Neijs S, Bruggenwirth HT et al (2010) Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations. Ann Neurol 68:876–887PubMedCrossRef
Zurück zum Zitat Van de Kamp JJ, Niermeijer MF, von Figura K, Giesberts MA (1981) Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clin Genet 20:152–160PubMedCrossRef Van de Kamp JJ, Niermeijer MF, von Figura K, Giesberts MA (1981) Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clin Genet 20:152–160PubMedCrossRef
Zurück zum Zitat Yogalingam G, Hopwood JJ (2001) Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications. Hum Mutat 18:264–281PubMedCrossRef Yogalingam G, Hopwood JJ (2001) Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications. Hum Mutat 18:264–281PubMedCrossRef
Zurück zum Zitat Zimmerman I, Steiner V, Pond R (2002) Preschool language scale, 4th edn. The Psychological Corp, San Antonio Zimmerman I, Steiner V, Pond R (2002) Preschool language scale, 4th edn. The Psychological Corp, San Antonio
Metadaten
Titel
Natural history of Sanfilippo syndrome type A
verfasst von
Dakota Buhrman
Kavita Thakkar
Michele Poe
Maria L. Escolar
Publikationsdatum
01.05.2014
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 3/2014
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9661-8

Weitere Artikel der Ausgabe 3/2014

Journal of Inherited Metabolic Disease 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.